Testing effectiveness (Phase 2)Study completedNCT02632448
What this trial is testing
LY2880070 in Participants With Advanced or Metastatic Cancer
Who this might be right for
Solid TumorsColorectal CancerBreast Cancer+9 more
Esperas Pharma Inc. 229
Showing 20 of 0 results